FTO and metabolic syndrome: The expression profile of the FTO gene was decreased by ∼1.37 fold in AF without the MetS group and by ∼1.14-fold in AF with the MetS group as compared to an increase by ∼3.84-fold in the control group, also representing a significant difference (Table 1).